Brainsway Ltd. (BWAY)
Stock Price:
$5.55 USD
0.03 (0.54%)
Updated Jul 10, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
61.75M |
| Revenue (ttm) |
22.08M |
| Net Income (ttm) |
-10.33M |
| Shares Out |
11.13M |
| EPS (ttm) |
-1.08 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Jul 10, 2020 |
| Last Price |
$5.55 |
| Previous Close |
$5.52 |
| Change ($) |
0.03 |
| Change (%) |
0.54% |
| Day's Open |
5.55 |
| Day's Range |
5.50 - 5.71 |
| Day's Volume |
9,397 |
| 52-Week Range |
5.10 - 12.53 |
More Stats
| Market Cap |
61.75M |
| Enterprise Value |
39.85M |
| Earnings Date (est) |
Aug 31, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
11.13M |
| Float |
3.65M |
| EPS (basic) |
-1 |
| EPS (diluted) |
-1.08 |
| FCF / Share |
-0.98 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
11,051 |
| Short Ratio |
1.47 |
| Short % of Float |
n/a |
| Beta |
0.63 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
2.80 |
| PB Ratio |
3.19 |
| Revenue |
22.08M |
| Operating Income |
-8.48M |
| Net Income |
-10.33M |
| Free Cash Flow |
-10.56M |
| Net Cash |
21.90M |
| Net Cash / Share |
1.97 |
| Gross Margin |
86.80% |
| Operating Margin |
-38.39% |
| Profit Margin |
-44.70% |
| FCF Margin |
-47.81% |
| ROA |
-19.59% |
| ROE |
-89.56% |
| ROIC |
-87.10% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (3)
| Buy |
2 |
| Overweight |
1 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$11.68*
(110.45% upside)
Low
10.0
Current: 5.55
High
13.0
Target: 11.68
*Average 12-month price target from 3 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 |
|---|
| Revenue | 23.10 | 16.40 | 11.15 |
| Revenue Growth | 40.89% | 47.12% | - |
| Gross Profit | 17.97 | 12.81 | 8.55 |
| Operating Income | -8.48 | -5.11 | -6.61 |
| Net Income | -10.33 | -6.48 | -7.05 |
| Shares Outstanding | 21.64 | 21.64 | - |
| Earnings Per Share | -1.00 | -0.78 | -0.96 |
| Operating Cash Flow | -7.24 | -3.77 | -3.47 |
| Capital Expenditures | -3.31 | -1.97 | -0.99 |
| Free Cash Flow | -10.56 | -5.75 | -4.45 |
| Cash & Equivalents | 21.90 | 9.07 | 14.56 |
| Total Debt | - | 2.83 | 2.73 |
| Net Cash / Debt | 21.90 | 6.24 | 11.83 |
| Assets | 38.74 | 23.60 | 27.03 |
| Liabilities | 14.52 | 16.65 | 14.31 |
| Book Value | 24.22 | 6.95 | 12.72 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Brainsway Ltd. |
| Country |
Israel |
| Employees |
107 |
| CEO |
Christopher von Jako |
Stock Information
| Ticker Symbol |
BWAY |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Diagnostics & Research |
| Unique Identifier |
NASDAQ: BWAY |
| IPO Date |
October 6, 1999 |
Description
Brainsway Ltd. engages in the development and provision of technology solutions for non-invasive treatment of brain disorders in Israel and internationally. It offers deep transcranial magnetic stimulation systems for treating various conditions, including autism, Alzheimer's disease, bipolar disorders, chronic pains, depressive disorders, Parkinson's diseases, schizophrenia, smoking cessation, post-traumatic stress disorders, multiple sclerosis, obsessive compulsive disorders, and stroke rehabilitation. Brainsway Ltd. was founded in 2003 and is based in Jerusalem, Israel.